Rohmann S, Weygandt H, Schelling P, Kie Soei L, Verdouw P D, Lues I
E. Merck, Department of Preclinical Cardiovascular Research, Darmstadt, Germany.
Basic Res Cardiol. 1994 Nov-Dec;89(6):563-76. doi: 10.1007/BF00794956.
Single or multiple brief periods of ischemia (preconditioning, PC) have been shown to protect the myocardium from infarction during a subsequent more prolonged ischemic insult. To test the hypothesis that opening of ATP-sensitive potassium channels (KATP) is involved in this mechanism, either bimakalim, a KATP channel opener, or glibenclamide, a KATP channel blocker, were administered to mimic or to block preconditioning protection in barbital-anesthetized pigs. PC was elicited by a single period of 10 min left anterior descending coronary artery (LADCA) occlusion followed by 15 min of reperfusion before the LADCA was reoccluded for 60 min. Instead of PC, bimakalim infusion was started 15 min before the 60 min LADCA occlusion (TCO) and stopped with the onset of ischemia. Glibenclamide was administered either for 10 min prior to the PC protocol, before bimakalim infusion, or before TCO. Regional wall function was quantified with ultrasonic crystals aligned to measure wall thickening (% delta WT). At the end of the protocol, infarct size was determined by incubating myocardium with p-nitrobluetetrazolium. In seven preconditioned pigs, infarct size was 9.9 +/- 5.1% of the risk region compared with 65.9 +/- 6.0% in the seven control pigs subjected to 60 min of ischemia only (p < 0.001). In seven pigs treated with bimakalim, infarct size was reduced to 35.3 +/- 6.6 (p < 0.05 vs. controls). Blocking ATP-sensitive potassium channels with glibenclamide prior to PC abolished its protective effect (infarct size, 62.2 +/- 4.5%; p < 0.001 vs. PC alone). Glibenclamide also antagonized the protective effect of bimakalim (infarct size, 55.2 +/- 4.0%), but did not affect infarct size, when solely administered prior to the prolonged ischemic period (62.2 +/- 4.3%). We conclude that in swine myocardium KATP channels are involved in the protective effect of ischemic preconditioning, since glibenclamide completely abolished the protective effect of preconditioning, while bimakalim could--at least in part--mimic it.
单次或多次短暂缺血(预处理,PC)已被证明可保护心肌在随后更长时间的缺血损伤中不发生梗死。为了验证ATP敏感性钾通道(KATP)开放参与这一机制的假说,在巴比妥麻醉的猪中分别给予KATP通道开放剂苄甲胍或KATP通道阻滞剂格列本脲,以模拟或阻断预处理保护作用。PC通过左冠状动脉前降支(LADCA)单次闭塞10分钟,随后再灌注15分钟,然后再次闭塞LADCA 60分钟来诱导。在60分钟LADCA闭塞(TCO)前15分钟开始输注苄甲胍而非进行PC,并在缺血开始时停止输注。格列本脲在PC方案前、苄甲胍输注前或TCO前给药10分钟。通过与测量室壁增厚(%ΔWT)的超声晶体对齐来量化局部室壁功能。在实验结束时,通过用对硝基蓝四氮唑孵育心肌来确定梗死面积。在7只预处理的猪中,梗死面积占危险区域的9.9±5.1%,而仅接受60分钟缺血的7只对照猪中梗死面积为65.9±6.0%(p<0.001)。在7只接受苄甲胍治疗的猪中,梗死面积减少至35.3±6.6(与对照组相比p<0.05)。在PC前用格列本脲阻断ATP敏感性钾通道可消除其保护作用(梗死面积,62.2±4.5%;与单独PC相比p<0.001)。格列本脲也拮抗苄甲胍的保护作用(梗死面积,55.2±4.0%),但在长时间缺血期前单独给药时不影响梗死面积(62.2±4.3%)。我们得出结论,在猪心肌中KATP通道参与缺血预处理的保护作用,因为格列本脲完全消除了预处理的保护作用,而苄甲胍至少部分地可模拟其作用。